首页> 外文期刊>Journal of research in medical sciences : >Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: A randomized trial comparing betamethasone and dexamethasone
【24h】

Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: A randomized trial comparing betamethasone and dexamethasone

机译:产前皮质类固醇激素对有早产风险的妇女的孕产妇血清感染指标的影响:一项比较倍他米松和地塞米松的随机试验

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To compare the effect of betamethasone and dexamethasone on maternal white blood cell (WBC) and differential count, erythrocyte sedimentation rate (ESR), Apgar score, maternal and fetal plasma glucose and length of admission to delivery, gestational age at delivery in women at risk of preterm labor (PTL). Study Design: Two hundred and forty pregnant women at risk for PTL with intact membranes or preterm premature rupture of the membranes (PPROM) were randomly allocated to receive either two intramuscular injections of 12 mg betamethasone at 24-h intervals or 4 injections of 6 mg dexamethasone at 12-h intervals. Blood tests for WBC and differential count, ESR and fasting plasma glucose were drawn before betamethasone or dexamethasone injection and after injection every 24 h for two days. Pregnancy outcome was assessed as Apgar score, fetal plasma glucose and length of gestation. Result: In the preterm delivery group with intact membranes, no significant differences were found between the two groups in the maternal serum indicators of infection. The mean gestational age at delivery, 1- and 5-min Apgar score were higher in the dexamethasone group than in the betamethasone group. In the PPROM group, a significant rise in WBC count was occurred (12.4 cells/mm(3) vs. 10.5 cells/mm(3), P < 0.001), none of the other maternal serum indicators of infection and outcome variables showed significant differences between the dexamethasone and betamethasone groups. Conclusions: Dexamethasone compared to betamethasone significantly increased WBC count in women with PPROM, but in women at risk of PTL with intact membranes none of the maternal serum indicators of infection showed significant differences.
机译:目的:比较倍他米松和地塞米松对孕妇白细胞(WBC),差异计数,红细胞沉降率(ESR),Apgar评分,母婴血浆葡萄糖和分娩住院时间,分娩孕龄的影响。有早产风险(PTL)。研究设计:240位有完整膜或早产膜早产破裂风险的孕妇(PPROM)被随机分配,每隔24小时接受两次肌肉注射12 mg倍他米松或4次注射6 mg地塞米松间隔12小时。在注射倍他米松或地塞米松之前以及每24h注射两天后,抽血检查白细胞,差异计数,血沉和空腹血糖。妊娠结局以Apgar评分,胎儿血浆葡萄糖和妊娠时间进行评估。结果:在胎膜完整的早产组中,两组孕妇血清感染指标之间无显着差异。地塞米松组的平均分娩胎龄,1分钟和5分钟Apgar评分高于倍他米松组。在PPROM组中,白细胞计数显着上升(12.4细胞/ mm(3)与10.5细胞/ mm(3),P <0.001),其他母体血清感染指标和结果变量均未显示地塞米松和倍他米松组之间的差异。结论:与倍他米松相比,地塞米松与PPROM妇女的WBC计数显着增加,但在具有完好膜的PTL风险的妇女中,母体感染指标均无明显差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号